* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Defense Lecture Study ppt. part 2 File
Immune system wikipedia , lookup
Psychoneuroimmunology wikipedia , lookup
Lymphopoiesis wikipedia , lookup
Monoclonal antibody wikipedia , lookup
Adaptive immune system wikipedia , lookup
Innate immune system wikipedia , lookup
Molecular mimicry wikipedia , lookup
Immunosuppressive drug wikipedia , lookup
Cancer immunotherapy wikipedia , lookup
Defense Lec Study 2 For Bio 260 Compiled and adapted from Marieb A&P 8th Edition Antibodies • Immunoglobulins—gamma globulin portion of blood • Proteins secreted by plasma cells • Capable of binding specifically with antigen detected by B cells Basic Antibody Structure • T-or Y-shaped monomer of four looping linked polypeptide chains • Two identical heavy (H) chains and two identical light (L) chains • Variable (V) regions of each arm combine to form two identical antigen-binding sites Basic Antibody Structure • Constant (C) region of stem determines – The antibody class (IgM, IgA, IgD, IgG, or IgE) – The cells and chemicals that the antibody can bind to – How the antibody class functions in antigen elimination Antigen-binding site Heavy chain variable region Heavy chain constant region Light chain variable region Light chain constant region Disulfide bond Hinge region Stem region (a) Figure 21.14a Classes of Antibodies • IgM – A pentamer; first antibody released – Potent agglutinating agent – Readily fixes and activates complement • IgA (secretory IgA) – Monomer or dimer; in mucus and other secretions – Helps prevent entry of pathogens Table 21.3 Classes of Antibodies • IgD – Monomer attached to the surface of B cells – Functions as a B cell receptor • IgG – Monomer; 75–85% of antibodies in plasma – From secondary and late primary responses – Crosses the placental barrier Classes of Antibodies • IgE – Monomer active in some allergies and parasitic infections – Causes mast cells and basophils to release histamine Table 21.3 Generating Antibody Diversity • Billions of antibodies result from somatic recombination of gene segments • Hypervariable regions of some genes increase antibody variation through somatic mutations • Each plasma cell can switch the type of H chain produced, making an antibody of a different class Antibody Targets • Antibodies inactivate and tag antigens – Form antigen-antibody (immune) complexes • Defensive mechanisms used by antibodies – Neutralization and agglutination (the two most important) – Precipitation and complement fixation Neutralization • Simplest mechanism • Antibodies block specific sites on viruses or bacterial exotoxins • Prevent these antigens from binding to receptors on tissue cells • Antigen-antibody complexes undergo phagocytosis Agglutination • Antibodies bind the same determinant on more than one cell-bound antigen • Cross-linked antigen-antibody complexes agglutinate – Example: clumping of mismatched blood cells Precipitation • Soluble molecules are cross-linked • Complexes precipitate and are subject to phagocytosis Complement Fixation and Activation • Main antibody defense against cellular antigens • Several antibodies bind close together on a cellular antigen • Their complement-binding sites trigger complement fixation into the cell’s surface • Complement triggers cell lysis Complement Fixation and Activation • Activated complement functions – Amplifies the inflammatory response – Opsonization – Enlists more and more defensive elements Adaptive defenses Humoral immunity Antigen Antigen-antibody complex Antibody Inactivates by Neutralization (masks dangerous parts of bacterial exotoxins; viruses) Agglutination (cell-bound antigens) Enhances Phagocytosis Fixes and activates Precipitation (soluble antigens) Enhances Complement Leads to Inflammation Cell lysis Chemotaxis Histamine release Figure 21.15 Monoclonal Antibodies • Commercially prepared pure antibody • Produced by hybridomas – Cell hybrids: fusion of a tumor cell and a B cell • Proliferate indefinitely and have the ability to produce a single type of antibody • Used in research, clinical testing, and cancer treatment Cell-Mediated Immune Response • T cells provide defense against intracellular antigens – Two types of surface receptors of T cells • T cell antigen receptors • Cell differentiation glycoproteins – CD4 or CD8 – Play a role in T cell interactions with other cells Cell-Mediated Immune Response • Major types of T cells – CD4 cells become helper T cells (TH) when activated – CD8 cells become cytotoxic T cells (TC) that destroy cells harboring foreign antigens • Other types of T cells – Regulatory T cells (TREG) – Memory T cells Adaptive defenses Cellular immunity Immature lymphocyte Red bone marrow T cell receptor Class II MHC protein T cell receptor Maturation CD4 cell Thymus Activation APC (dendritic cell) Activation Memory cells CD4 Class I MHC protein CD8 cell APC (dendritic cell) CD8 Lymphoid tissues and organs Helper T cells (or regulatory T cells) Effector cells Blood plasma Cytotoxic T cells Figure 21.16 Comparison of Humoral and CellMediated Response • Antibodies of the humoral response – The simplest ammunition of the immune response • Targets – Bacteria and molecules in extracellular environments (body secretions, tissue fluid, blood, and lymph) Comparison of Humoral and CellMediated Response • T cells of the cell-mediated response – Recognize and respond only to processed fragments of antigen displayed on the surface of body cells • Targets – Body cells infected by viruses or bacteria – Abnormal or cancerous cells – Cells of infused or transplanted foreign tissue Antigen Recognition • Immunocompetent T cells are activated when their surface receptors bind to a recognized antigen (nonself) • T cells must simultaneously recognize – Nonself (the antigen) – Self (an MHC protein of a body cell) MHC Proteins • Two types of MHC proteins are important to T cell activation – Class I MHC proteins - displayed by all cells except RBCs – Class II MHC proteins – displayed by APCs (dendritic cells, macrophages and B cells) • Both types are synthesized at the ER and bind to peptide fragments Class I MHC Proteins • Bind with fragment of a protein synthesized in the cell (endogenous antigen) • Endogenous antigen is a self-antigen in a normal cell; a nonself antigen in an infected or abnormal cell • Informs cytotoxic T cells of the presence of microorganisms hiding in cells (cytotoxic T cells ignore displayed self-antigens) Cytoplasm of any tissue cell 2 Endogenous antigen 1 Endogenous peptides enter ER via antigen is degraded transport protein. by protease. Endogenous antigen— self-protein or foreign (viral or cancer) protein Cisternae of endoplasmic reticulum (ER) 3 Endogenous antigen peptide is loaded onto class I MHC protein. 4 Loaded MHC protein migrates in vesicle to the plasma membrane, where it displays the antigenic peptide. Transport protein (ATPase) Plasma membrane of a tissue cell Antigenic peptide Extracellular fluid (a) Endogenous antigens are processed and displayed on class I MHC of all cells. Figure 21.17a Class II MHC Proteins • Bind with fragments of exogenous antigens that have been engulfed and broken down in a phagolysosome • Recognized by helper T cells T Cell Activation • • APCs (most often a dendritic cell) migrate to lymph nodes and other lymphoid tissues to present their antigens to T cells T cell activation is a two-step process 1. Antigen binding 2. Co-stimulation T Cell Activation: Antigen Binding • CD4 and CD8 cells bind to different classes of MHC proteins (MHC restriction) • CD4 cells bind to antigen linked to class II MHC proteins of APCs • CD8 cells are activated by antigen fragments linked to class I MHC of APCs T Cell Activation: Antigen Binding • Dendritic cells are able to obtain other cells’ endogenous antigens by – Engulfing dying virus-infected or tumor cells – Importing antigens through temporary gap junctions with infected cells • Dendritic cells then display the endogenous antigens on both class I and class II MHCs T Cell Activation: Antigen Binding • TCR that recognizes the nonself-self complex is linked to multiple intracellular signaling pathways • Other T cell surface proteins are involved in antigen binding (e.g., CD4 and CD8 help maintain coupling during antigen recognition) • Antigen binding stimulates the T cell, but costimulation is required before proliferation can occur Adaptive defenses Cellular immunity 1 Dendritic cell Viral antigen Dendritic cell T cell receptor (TCR) Clone formation Class lI MHC protein displaying processed viral antigen CD4 protein engulfs an exogenous antigen, processes it, and displays its fragments on class II MHC protein. 2 Immunocompetent CD4 cell recognizes antigen-MHC complex. Both TCR and CD4 protein bind Immunocom- to antigen-MHC complex. petent CD4 T cell 3 CD4 cells are activated, proliferate (clone), and become memory and effector cells. Helper T memory cell Activated helper T cells Figure 21.18 T Cell Activation: Co-Stimulation • Requires T cell binding to other surface receptors on an APC – Dendritic cells and macrophages produce surface B7 proteins when innate defenses are mobilized – B7 binding with a CD28 receptor on a T cell is a crucial costimulatory signal • Cytokines (interleukin 1 and 2 from APCs or T cells) trigger proliferation and differentiation of activated T cell T Cell Activation: Co-Stimulation • Without co-stimulation, anergy occurs – T cells • Become tolerant to that antigen • Are unable to divide • Do not secrete cytokines T Cell Activation: Co-Stimulation • T cells that are activated – Enlarge, proliferate, and form clones – Differentiate and perform functions according to their T cell class T Cell Activation: Co-Stimulation • Primary T cell response peaks within a week • T cell apoptosis occurs between days 7 and 30 • Effector activity wanes as the amount of antigen declines • Benefit of apoptosis: activated T cells are a hazard • Memory T cells remain and mediate secondary responses Cytokines • Mediate cell development, differentiation, and responses in the immune system • Include interleukins and interferons • Interleukin 1 (IL-1) released by macrophages co-stimulates bound T cells to – Release interleukin 2 (IL-2) – Synthesize more IL-2 receptors Cytokines • IL-2 is a key growth factor, acting on cells that release it and other T cells – Encourages activated T cells to divide rapidly – Used therapeutically to treat melanoma and kidney cancers • Other cytokines amplify and regulate innate and adaptive responses Roles of Helper T(TH) Cells • Play a central role in the adaptive immune response • Once primed by APC presentation of antigen, they – Help activate T and B cells – Induce T and B cell proliferation – Activate macrophages and recruit other immune cells • Without TH, there is no immune response Helper T Cells • Interact directly with B cells displaying antigen fragments bound to MHC II receptors • Stimulate B cells to divide more rapidly and begin antibody formation • B cells may be activated without TH cells by binding to T cell–independent antigens • Most antigens require TH co-stimulation to activate B cells TH cell help in humoral immunity Activated helper T cell 1 TH cell binds with the Helper T cell CD4 protein self-nonself complexes of a B cell that has encountered its antigen and is displaying it on MHC II on its surface. MHC II protein of B cell displaying processed antigen 2 TH cell releases T cell receptor (TCR) IL- 4 and other cytokines interleukins as co-stimulatory signals to complete B cell activation. B cell (being activated) (a) Figure 21.19a Helper T Cells • Cause dendritic cells to express co-stimulatory molecules required for CD8 cell activation TH cell help in cell-mediated immunity CD4 protein Helper T cell 1 Previously activated TH cell binds dendritic cell. Class II MHC protein APC (dendritic cell) 2 TH cell stimulates IL-2 dendritic cell to express co-stimulatory molecules (not shown) needed to activate CD8 cell. 3 Dendritic cell can Class I MHC protein (b) CD8 protein CD8 T cell now activate CD8 cell with the help of interleukin 2 secreted by TH cell. Figure 21.19b Roles of Cytotoxic T(TC) Cells • Directly attack and kill other cells • Activated TC cells circulate in blood and lymph and lymphoid organs in search of body cells displaying antigen they recognize Roles of Cytotoxic T(TC) Cells • Targets – Virus-infected cells – Cells with intracellular bacteria or parasites – Cancer cells – Foreign cells (transfusions or transplants) Cytotoxic T Cells • Bind to a self-nonself complex • Can destroy all infected or abnormal cells Cytotoxic T Cells • Lethal hit – Tc cell releases perforins and granzymes by exocytosis – Perforins create pores through which granzymes enter the target cell – Granzymes stimulate apoptosis • In some cases, TC cell binds with a Fas receptor on the target cell, and stimulates apoptosis Adaptive defenses Cytotoxic T cell (TC) Cellular immunity 1 TC binds tightly to the target cell when it identifies foreign antigen on MHC I proteins. granzyme molecules from its granules by exocytosis. Granule Perforin TC cell membrane Target cell membrane Target cell 2 TC releases perforin and Perforin pore Granzymes 5 The TC detaches and 3 Perforin molecules insert into the target cell membrane, polymerize, and form transmembrane pores (cylindrical holes) similar to those produced by complement activation. 4 Granzymes enter the target cell via the pores. Once inside, these proteases degrade cellular contents, stimulating apoptosis. searches for another prey. (a) A mechanism of target cell killing by TC cells. Figure 21.20a Natural Killer Cells • Recognize other signs of abnormality – Lack of class I MHC – Antibody coating a target cell – Different surface marker on stressed cells • Use the same key mechanisms as Tc cells for killing their target cells Regulatory T (TReg) Cells • Dampen the immune response by direct contact or by inhibitory cytokines • Important in preventing autoimmune reactions Cell-mediated immunity Antigen (Ag) intruder Humoral immunity Inhibits Inhibits Triggers Adaptive defenses Innate defenses Surface Internal barriers defenses Ag-infected body cell engulfed by dendritic cell Becomes Ag-presenting cell (APC) presents self-Ag complex Activates Free Ags may directly activate B cell Antigenactivated B cells Clone and give rise to Activates Naïve Naïve CD8 CD4 T cells T cells Activated to clone Activated to clone and give rise to Induce and give rise to co-stimulation Memory cytotoxic T cells Activated cytotoxic T cells Memory helper T cells Activated helper T cells Memory B cells Plasma cells (effector B cells) Secrete Cytokines stimulate Together the nonspecific killers and cytotoxic T cells mount a physical attack on the Ag Nonspecific killers (macrophages and NK cells of innate immunity) Antibodies (Igs) Circulating lgs along with complement mount a chemical attack on the Ag Figure 21.21 Organ Transplants • Four varieties – Autografts: from one body site to another in the same person – Isografts: between identical twins – Allografts: between individuals who are not identical twins – Xenografts: from another animal species Prevention of Rejection • Depends on the similarity of the tissues • Patient is treated with immunosuppressive therapy – Corticosteroid drugs to suppress inflammation – Antiproliferative drugs – Immunosuppressant drugs • Many of these have severe side effects Immunodeficiencies • Congenital and acquired conditions that cause immune cells, phagocytes, or complement to behave abnormally Severe Combined Immunodeficiency (SCID) Syndrome Genetic defect • • Marked deficit in B and T cells • Abnormalities in interleukin receptors • Defective adenosine deaminase (ADA) enzyme – Metabolites lethal to T cells accumulate • SCID is fatal if untreated; treatment is with bone marrow transplants Hodgkin’s Disease • An acquired immunodeficiency • Cancer of the B cells • Leads to immunodeficiency by depressing lymph node cells Acquired Immune Deficiency Syndrome (AIDS) • Cripples the immune system by interfering with the activity of helper T cells • Characterized by severe weight loss, night sweats, and swollen lymph nodes • Opportunistic infections occur, including pneumocystis pneumonia and Kaposi’s sarcoma Acquired Immune Deficiency Syndrome (AIDS) • Caused by human immunodeficiency virus (HIV) transmitted via body fluids—blood, semen, and vaginal secretions • HIV enters the body via – Blood transfusions – Blood-contaminated needles – Sexual intercourse and oral sex • HIV – Destroys TH cells – Depresses cell-mediated immunity Acquired Immune Deficiency Syndrome (AIDS) • HIV multiplies in lymph nodes throughout the asymptomatic period • Symptoms appear in a few months to 10 years • HIV-coated glycoprotein complex attaches to the CD4 receptor • HIV enters the cell and uses reverse transcriptase to produce DNA from viral RNA • The DNA copy (a provirus) directs the host cell to make viral RNA and proteins, enabling the virus to reproduce Acquired Immune Deficiency Syndrome (AIDS) • HIV reverse transcriptase produces frequent transcription errors; high mutation rate and resistance to drugs • Treatment with antiviral drugs • Reverse transcriptase inhibitors (AZT) – Protease inhibitors (saquinavir and ritonavir) – New Fusion inhibitors that block HIV’s entry to helper T cells Autoimmune Diseases • Immune system loses the ability to distinguish self from foreign • Production of autoantibodies and sensitized TC cells that destroy body tissues • Examples include multiple sclerosis, myasthenia gravis, Graves’ disease, type I diabetes mellitus, systemic lupus erythematosus (SLE), glomerulonephritis, and rheumatoid arthritis Mechanisms of Autoimmune Diseases 1. Foreign antigens may resemble self-antigens – Antibodies against the foreign antigen may cross-react with self-antigen 2. New self-antigens may appear, generated by – – Gene mutations Changes in self-antigens by hapten attachment or as a result of infectious damage Mechanisms of Autoimmune Diseases 3. Release of novel self-antigens by trauma of a barrier (e.g., the blood-brain barrier) Hypersensitivities • Immune responses to a perceived (otherwise harmless) threat • Causes tissue damage • Different types are distinguished by – Their time course – Whether antibodies or T cells are involved • Antibodies cause immediate and subacute hypersensitivities • T cells cause delayed hypersensitivity Immediate Hypersensitivity • Acute (type I) hypersensitivities (allergies) begin in seconds after contact with allergen • Initial contact is asymptomatic but sensitizes the person • Reaction may be local or systemic Immediate Hypersensitivity • The mechanism involves IL-4 secreted by T cells • IL-4 stimulates B cells to produce IgE • IgE binds to mast cells and basophils, resulting in a flood of histamine release and inducing the inflammatory response Anaphylactic Shock • Systemic response to allergen that directly enters the blood • Basophils and mast cells are enlisted throughout the body • Systemic histamine releases may cause – Constriction of bronchioles – Sudden vasodilation and fluid loss from the bloodstream – Hypotensive shock and death • Treatment: epinephrine Subacute Hypersensitivities • Caused by IgM and IgG transferred via blood plasma or serum • Slow onset (1–3 hours) and long duration (10–15 hours) • Cytotoxic (type II) reactions – Antibodies bind to antigens on specific body cells, stimulating phagocytosis and complement-mediated lysis of the cellular antigens – Example: mismatched blood transfusion reaction Subacute Hypersensitivities • Immune complex (type III) hypersensitivity – Antigens are widely distributed through the body or blood – Insoluble antigen-antibody complexes form – Complexes cannot be cleared from a particular area of the body – Intense inflammation, local cell lysis, and death may result – Example: systemic lupus erythematosus (SLE) Delayed Hypersensitivities (Type IV) • Slow onset (one to three days) • Mechanism depends on helper T cells • Cytokine-activated macrophages and cytotoxic T cells cause damage • Example: allergic contact dermatitis (e.g., poison ivy) Developmental Aspects • Immune system stem cells develop in the liver and spleen by the ninth week • Bone marrow becomes the primary source of stem cells • Lymphocyte development continues in the bone marrow and thymus Developmental Aspects • TH2 lymphocytes predominate in the newborn, and the TH1 system is educated as the person encounters antigens • The immune system is impaired by stress and depression • With age, the immune system begins to wane, and incidence of cancer increases